Full-Time

Director of Product Management

Posted on 10/31/2025

Radformation

Radformation

51-200 employees

FDA-cleared software for radiation therapy planning

Compensation Overview

$225k - $250k/yr

Remote in USA

Remote

Category
Product (2)
,
Requirements
  • Minimum 5  years of software product management experience, including operational management and delivery across multiple products or product lines
  • Minimum 3 years in a software product leadership role, directly managing and mentoring product managers and product management teams and driving cross‑functional alignment
  • Verification and/or validation testing management and completion
  • Regulatory and/or Quality Management System experience
  • General understanding of radiation oncology workflows
  • Abilities: Enthusiastic about learning new technologies and sharing them with the healthcare community
  • General understanding of  radiation oncology clinical workflow
  • Thrives with a dynamic schedule and constant learning environment
  • Excels at multi-tasking and managing multiple projects simultaneously
  • Strong critical thinking and problem solving abilities
  • Proven organizational skills with the ability to work independently
  • Exceptional communication skills and attention to detail
  • Passion to drive timelines and motivate team members
  • Positive attitude and a commitment to excellence in patient care
  • Open mindset and welcoming of ideas and feedback
Responsibilities
  • Oversee and manage product timelines, workflows, and ensure timely product releases, keeping teams aligned and focused on meeting deadlines
  • Monitor and analyze product progress, ensuring timely feature implementation and identifying bottlenecks
  • Partner closely with the VP of Product to execute the defined product strategy and roadmap, bringing clarity, structure, and operational leadership to the product management organization
  • Lead and mentor product managers, fostering innovation and continuous process improvements to optimize product workflows
  • Collaborate cross-functionally - including with Regulatory Affairs and the Director of Product Quality - to align market requirements with quality standards and regulatory requirements
  • Drive operational efficiency through strategic partnerships, resource allocation, and meticulous release calendar management
  • Manage administrative tasks, such as hiring, headcount, and onboarding
  • Track support channels and key performance metrics to identify adoption challenges and develop actionable improvement plans
  • Ensure comprehensive documentation generation for product releases, maintaining clarity and compliance across all markets
Desired Qualifications
  • 7+ years experience as a clinical medical physicist using Radformation products
  • Personnel management experience
  • Product management with Jira or similar product management software
  • Experience with multiple treatment planning systems
  • Experience using Visual Studios or similar coding software
  • Programming experience using C#
  • Customer service experience

Radformation provides FDA-cleared software tools for radiation therapy treatment planning to help clinics improve quality and efficiency. Its product suite includes ClearCheck for automated plan checks and documentation, ClearCalc for independent dose validation, EZFluence for generating 3D treatment plans, AutoContour an AI-driven contouring tool, ChartCheck for real-time patient data monitoring, and QuickCode for billing QA. These tools integrate into existing clinical workflows and are offered via software licenses with support services. Compared to competitors, Radformation offers a cohesive, FDA-cleared, multi-tool platform that covers plan checks, dose validation, plan generation, AI-assisted contouring, data monitoring, and billing QA in one ecosystem. The company’s goal is to streamline the entire treatment planning process, helping radiation oncology departments save time and resources while ensuring accurate, high-quality patient care.

Company Size

51-200

Company Stage

Early VC

Total Funding

$9.2M

Headquarters

New York City, New York

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • ChartCheck Adaptive expanded FDA 510(k) clearance supports adaptive radiotherapy monitoring growth.
  • Limbus AI acquisition strengthens AI contouring and expands cross-sell across 2,000 clinics.
  • International clearances in Australia, Brazil, Canada, and Thailand open multi-country sales expansion.

What critics are saying

  • Varian can bundle competing automation inside Eclipse and squeeze Radformation’s pricing.
  • AI contouring commoditization erodes AutoContour differentiation as TPS vendors add native features.
  • Integration across acquired and existing products can delay releases and fragment customer workflows.

What makes Radformation unique

  • Clinical physicist founders built workflow software from firsthand treatment-planning pain points.
  • Vendor-neutral tools integrate across Eclipse, RayStation, and Monaco treatment planning systems.
  • AutoContour, ClearCheck, ClearCalc, and EZFluence cover planning, verification, and QA workflows.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Radformation who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Parental Leave

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

0%

2 year growth

1%
Business Wire
Feb 18th, 2026
Icon Group deploys ChartCheck Adaptive across 15 Australian cancer centres as Radformation gains US FDA 510(k) clearance

Icon Group has deployed ChartCheck Adaptive, Radformation's offline adaptive assessment solution, across 15 cancer centres in Australia. The rollout began in November and will expand to all Icon Cancer Centre locations globally in the coming months. The technology provides automated, quantitative insight into daily treatment delivery, particularly benefiting head and neck cancer cases. Early results show several patients were successfully re-planned due to anatomical changes during treatment, supporting clinical decision-making whilst maintaining efficient workflows. Radformation has secured expanded US FDA 510(k) clearance for ChartCheck to support the new adaptive functionality. The software evaluates daily imaging and treatment data to assess how dose and anatomy change throughout treatment. Icon Group, serving over 55 cancer centres globally, has partnered with Radformation as an early adopter and Centre of Excellence member.

Radformation
Jan 7th, 2025
Upcoming Release: AutoContour v2.6 Offers 95 Brand New Structure Models

Radformation is thrilled to announce the upcoming release of AutoContour v2.6, packed with exciting features, enhancements, and additional structure models.

Business Wire
May 3rd, 2024
Radformation to Accelerate AI-Based Solutions with Limbus AI Acquisition

Radformation, Inc. has acquired Limbus AI. This merger combines their strengths to advance AI-driven solutions, aiming to enhance patient care.

Business Wire
May 1st, 2024
Radformation Acquires Limbus AI

Radformation, a leader in cancer care automation, has acquired Limbus AI, a top provider of automated contouring software for radiation therapy. This merger enhances Radformation's AI capabilities and aims to integrate the best features of both companies' technologies, promising advancements in radiation therapy. The combined entity will now serve over 2,000 clinics globally, impacting 500,000 patients. This strategic move is set to drive innovation and improve patient outcomes in healthcare technology.

Business Wire
Feb 22nd, 2024
Radformation Recebe Autorizações Regulatórias Para Soluções De Automação Na Austrália, Brasil, Canadá E Tailândia

NOVA YORK--(BUSINESS WIRE)--Radformation, líder em soluções de software clínico e operacional para tratamento do câncer, anunciou hoje que recebeu autorizações regulatórias para suas soluções de automação de radioterapia* da Therapeutic Goods Administration (TGA) na Austrália, da Agência Nacional de Vigilância Sanitária (ANVISA) no Brasil, da Health Canada no Canadá e da Administração de Alimentos e Medicamentos (FDA) na Tailândia. “Essas autorizações refletem nosso compromisso com a inovação global em saúde e nossa dedicação em atender aos rigorosos padrões regulatórios essenciais para melhorar o atendimento aos pacientes no mundo inteiro”, disse Kurt Sysock, CEO da Radformation. Incluído nessas autorizações está o AutoContour, a solução de segmentação e perfilamento automática baseada em IA da Radformation, projetado para iniciar o processo de planejamento do tratamento. Em um estudo de caso recente, o AutoContour demonstrou diminuir o tempo de planejamento do perfilamento em uma média de 84% em todos os locais anatômicos, gerando perfilamentos altamente precisos, levando a uma melhor consistência do plano de tratamento. Os primeiros usuários brasileiros do AutoContour e do ClearCheck, o software automatizado de verificação de plano secundário da Radformation, a Liga Catarinense de Combate ao Câncer - Radioterapia São Sebastião e o Real Hospital Português de Beneficência, selecionaram as ferramentas da Radformation para complementar suas crescentes modalidades de tratamento de última geração e expandir a carga de pacientes

INACTIVE